`
`
`
`SUN PHARMACEUTICAL INDUSTRIES LTD.
`and
`SUN PHARMACEUTICAL INDUSTRIES, INC.,
`
`Petitioners,
`
`V.
`
`NOVO NORDISKA/S,
`Patent Owner.
`
`U.S. Patent No. 10,335,462 to Jensen
`Issue Date: July 2, 2019
`Title: Use of Long-Acting GLP-1 Peptides
`
`Inter Partes Review No. IPR2024-00107
`
`PETITIONER’S POWER OF ATTORNEY
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Pursuant to 37 C.F.R. 42.10(b), Petitioners Sun Pharmaceutical Industries
`
`Ltd. and Sun Pharmaceutical Industries Inc. hereby appoint the following lead and
`
`back-up counsel to transact all business before the Patent Trial & Appeal Board of
`
`the United States Patent and Trademark Office in connection with a Petition for
`
`Inter Partes Review of U.S. Patent No. 10,335,462 entitled “Use of Long-acting
`
`GLP-1 Peptides.”
`
`~ Lead Counsel
`
`
`Back-Up Counsel
`
`
`Christopher B. Ferenc
`Reg No. 59,365
`Katten Muchin Rosenman LLP
`1919 Pennsylvania Ave., N.W.
`Suite 800
`Washington, DC 20006
`Phone: (202) 625-3500
`
`
`
`Brian Sodikoff
`Reg No. 54,697
`Katten Muchin Rosenman LLP
`525 West MonroeStreet
`Chicago, IL 60661
`Phone:(312) 902-5200
`
`Back-Up Counsel
`
`
`Christopher West
`Reg. No. 74,724
`Katten Muchin Rosenman LLP
`550 South Tryon Street
`Suite 2900
`Charlotte, NC 28202
`Phone: (704) 444-2000
`
`
`
`
`
`The undersignedis authorized to sign this Power of Attorney on behalf of Sun
`
`Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.
`
`By:CPee
`
`Name:
`
`;
`
`Kv Wty
`
`Title: AVP
`
`] FP
`
`
`
`Date:
`
`(/
`
`20
`
`